STOCK TITAN

Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

Azora Therapeutics (AZR) granted one new non-executive employee an option to buy 40,000 common shares as a hiring inducement. The grant took effect on November 16, 2026, under the 2026 Employment Inducement Equity Incentive Plan. The option has a $3.81-per-share exercise price, equal to the stock’s closing price on that date, and a ten-year term.

The option vests over four years: 25% on the first anniversary of the grant date and the rest in equal monthly installments, subject to continued service through each vesting date.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.Option for 40,000 common shares could dilute existing shareholders if exercised at $3.81 per share.

Key Figures

Option award: 40,000 shares Exercise price: $3.81 per share Option term: 10 years +1 more
Option award
40,000 shares
Granted to one new non-executive employee
Exercise price
$3.81 per share
Closing stock price on the grant's effective date
Option term
10 years
Term of the option award
Vesting period
Four years
25% vests on the first anniversary; the remainder vests in equal monthly installments

Key Terms

exercise price, vesting, nasdaq listing rule 5635(c)(4)
3 terms
exercise price financial
"The option award has an exercise price of $3.81 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option award will vest over four years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
nasdaq listing rule 5635(c)(4) regulatory
"in accordance with Nasdaq Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LOS ANGELES, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Azora Therapeutics, Inc. (NASDAQ: AZR) (the “Company”), a biopharmaceutical company developing treatments for serious inflammatory diseases, announced today that the Compensation Committee of its Board of Directors granted an option to purchase 40,000 shares of the Company’s common stock under the Azora Therapeutics, Inc. 2026 Employment Inducement Equity Incentive Plan (the “2026 Inducement Plan”) to one new non-executive employee as an inducement material to such person entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

The option award has an exercise price of $3.81 per share, the closing price of the Company’s common stock on November 16, 2026, the effective date of grant, and has a ten-year term. The option award will vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments thereafter, subject to the recipient’s continued service through each applicable vesting date. The option award is subject to the terms and conditions of the 2026 Inducement Plan and the terms and conditions of an option award agreement covering the grant.

The 2026 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of the Company or its parent or subsidiaries, or following a bona fide period of non-employment, as an inducement material to such individuals’ entering into employment with the Company, pursuant to Nasdaq Listing Rule 5635(c)(4).

About Azora Therapeutics, Inc.

Azora Therapeutics is a biopharmaceutical company focused on developing treatments for serious inflammatory diseases. The company was launched out of Stanford University after being incubated in the translational medicine SPARK program. Azora owns worldwide royalty-free rights to its technology, which is based on the development of oral agonists of the aryl hydrocarbon receptor. Azora’s lead program is AT177, a proprietary colon-targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure, in development for ulcerative colitis. More information on Azora can be found on the company’s website at www.AzoraTherapeutics.com.

Investor Contact:

Mike Moyer
Managing Director
LifeSci Advisors, LLC
Phone: (617) 328-4326
Email: mmoyer@lifesciadvisors.com 

Media Contact:

Ashley Biladeau
Inizio Evoke Comms
Email: Ashley.Biladeau@inizioevoke.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does Azora Therapeutics’ inducement option cover, and what is the exercise price?

The inducement option covers 40,000 common shares at $3.81 per share. The exercise price matched the stock’s closing price on November 16, 2026, the grant’s effective date. The option has a ten-year term.

Who is eligible for awards under Azora Therapeutics’ 2026 Employment Inducement Equity Incentive Plan?

The plan is limited to new hires and individuals returning after a genuine period of non-employment. Awards are used as a material inducement to join Azora; the new-hire category excludes anyone previously employed by Azora, its parent or its subsidiaries.

Keep reading